Literature DB >> 20222848

Roles of an anti-tuberculosis medication and surgery in patients with tuberculous otitis media.

Minsu Kwon1, Seung Hyo Choi, Jong Woo Chung.   

Abstract

CONCLUSION: The standard treatment for tuberculous otitis media (TOM) without complications consists of anti-tuberculosis (anti-TB) medication, with which we experienced good treatment outcomes. However, surgery is required for recovery of anatomy and hearing function.
OBJECTIVE: To determine the clinical characteristics of TOM that might optimize diagnosis and to evaluate the differences in clinical courses between patients treated with and without surgery.
METHODS: We analyzed 14 patients (16 ears) who had been diagnosed and treated for TOM. Radiologic findings, laboratory data, and audiometry results were also evaluated. Patients were divided into a chemotherapy group and a surgery group according to treatment modality.
RESULTS: Temporal bone CT (TBCT) showed total occupation of the tympanic cavity by soft tissue and little evidence of ossicular erosion. In the chemotherapy group, dry ears were obtained in all but one patient (14 ears) after treatment. Normalized tympanic membrane (TM) was found in 50% in the chemotherapy group and in 75% in the surgery group. The air-bone gap (ABG) changed from 40.3 +/- 2.5 dB to 47.0 +/- 19.2 dB in the chemotherapy group and from 35.2 +/- 7.6 dB to 30.2 +/- 11.4 dB in the surgery group. After treatment, ABG improved by > 10 dB in one ear in the chemotherapy group and in four ears in the surgery group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20222848     DOI: 10.3109/00016480903311260

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Primary bilateral tuberculous otitis media with peripheral facial paralysis: a case report and literature review.

Authors:  Ming Guan; Jie Zhang; Yuezhi Jia; Yaoshu Teng; Xiaolin Cao; Yong Li
Journal:  Int J Clin Exp Pathol       Date:  2021-03-01

2.  Two new cases of chronic tuberculous otomastoiditis in children.

Authors:  A Scorpecci; E Bozzola; A Villani; P Marsella
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-04       Impact factor: 2.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.